ATE143801T1 - Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben - Google Patents

Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Info

Publication number
ATE143801T1
ATE143801T1 AT93916292T AT93916292T ATE143801T1 AT E143801 T1 ATE143801 T1 AT E143801T1 AT 93916292 T AT93916292 T AT 93916292T AT 93916292 T AT93916292 T AT 93916292T AT E143801 T1 ATE143801 T1 AT E143801T1
Authority
AT
Austria
Prior art keywords
active substance
composition
pct
producing
same
Prior art date
Application number
AT93916292T
Other languages
English (en)
Inventor
Arie Cornelis Besemer
Coenraad Ferdinand Lerk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE143801T1 publication Critical patent/ATE143801T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT93916292T 1992-07-03 1993-07-02 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben ATE143801T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9201195A NL9201195A (nl) 1992-07-03 1992-07-03 Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number Publication Date
ATE143801T1 true ATE143801T1 (de) 1996-10-15

Family

ID=19861014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916292T ATE143801T1 (de) 1992-07-03 1993-07-02 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Country Status (12)

Country Link
US (1) US5585114A (de)
EP (1) EP0648116B1 (de)
JP (1) JPH07508533A (de)
AT (1) ATE143801T1 (de)
AU (1) AU678166B2 (de)
CA (1) CA2139494A1 (de)
DE (1) DE69305346T2 (de)
DK (1) DK0648116T3 (de)
ES (1) ES2095658T3 (de)
GR (1) GR3022195T3 (de)
NL (1) NL9201195A (de)
WO (1) WO1994001092A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401572A (nl) * 1994-09-27 1996-05-01 Avebe Coop Verkoop Prod Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
FR2743496B1 (fr) * 1996-01-15 1998-04-10 Univ Rennes Composite macroporeux support de substance(s) medicamenteuse(s) utilisable comme materiau de reconstitution osseuse et procede d'elaboration
GB9605857D0 (en) * 1996-03-20 1996-05-22 Tester Richard F Polysaccharides as chemical release systems
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
CA2211778A1 (en) * 1997-08-14 1999-02-14 Francois Carriere Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
AU1786799A (en) * 1997-12-18 1999-07-05 Instituut Voor Agrotechnologisch Onderzoek (Ato-Dlo) Composition for the controlled release of active compounds
WO2002072033A2 (en) 2001-03-13 2002-09-19 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
JP3742335B2 (ja) * 2001-12-20 2006-02-01 富士通株式会社 入出力バッファ回路
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
US6929817B2 (en) * 2002-05-14 2005-08-16 National Starch & Chemical Investment Holding Corporation Slowly digestible starch product
US6890571B2 (en) * 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
WO2005005484A1 (ja) 2003-07-11 2005-01-20 Asahi Kasei Chemicals Corporation 機能性澱粉粉末
US20070071810A1 (en) * 2003-08-26 2007-03-29 Kenichi Kudo Additive for tablets
AP2006003585A0 (en) 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
CA2624278A1 (en) 2005-12-09 2007-06-14 Sca Hygiene Products Ab Absorbent product
JP5608167B2 (ja) * 2008-10-23 2014-10-15 ヘンケル コーポレイション 加工デンプンを含む医薬ペレット、およびそれの治療への応用
WO2011117884A1 (en) * 2010-03-22 2011-09-29 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
GB1072795A (en) * 1963-08-28 1967-06-21 Eastman Kodak Co Solid composition containing fat-soluble vitamins and processes for making it
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
WO1985003414A1 (en) * 1984-01-31 1985-08-15 Scm Corporation Encapsulation matrix composition and encapsulate containing same
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds

Also Published As

Publication number Publication date
CA2139494A1 (en) 1994-01-20
DE69305346T2 (de) 1997-04-30
EP0648116A1 (de) 1995-04-19
AU4589393A (en) 1994-01-31
DK0648116T3 (da) 1997-03-24
WO1994001092A1 (en) 1994-01-20
AU678166B2 (en) 1997-05-22
DE69305346D1 (de) 1996-11-14
ES2095658T3 (es) 1997-02-16
NL9201195A (nl) 1994-02-01
JPH07508533A (ja) 1995-09-21
US5585114A (en) 1996-12-17
EP0648116B1 (de) 1996-10-09
GR3022195T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
ATE143801T1 (de) Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
WO2008025840A2 (de) Strukturierte beschichtungen für implantate sowie verfahren zu deren herstellung
EP0814659A4 (de) Zusammensetzungen mit kontrollierter freigabe und verfahren zur behandlung von organismen in der umwelt
ATE269371T1 (de) Injektierbare, keramische verbindungen sowie verfahren zu deren herstellung und anwendung
DE69128621D1 (de) Biokeramisches system zur abgabe von bioaktiven stoffen
EP0402031A3 (de) Injizierbare polymere Körper
ATE182278T1 (de) Teilchen, methode zur herstellung der teilchen und deren verwendung
UA27698C2 (uk) Спосіб одержання мікрокапсули поліпептиду
ATE179886T1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
ES8802434A1 (es) Un procedimiento para la preparacion de un polisiloxano macromero con grupos polimerizables no saturados.
CA2199993A1 (en) Methods of delivering materials into the skin, and compositions used therein
KR100310277B1 (ko) 뼈 형성 촉진용 저분자량 하이알루론산의 제조
DE69311404T2 (de) Bindemittel und seine Verwendungen
CA2423783A1 (en) Inhibition of systemic infections in humans and vertebrates by dietary fibers
ATE145821T1 (de) Zusammenfassung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselbe
DK0722477T3 (da) Vandige polymerisatfremstillinger
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
HUT58263A (en) Galacto-mannane derivatives for coating and incorporating pharmaceutical active components
MX9709614A (es) Composiciones emulsificadas de 1-4-bis(bromoacetoxi)-2-buteno utiles como un microbicida y conservador.
GEP20022840B (en) Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
ATE156842T1 (de) Oligosaccharide mit biologischer aktivität und verfahren zur herstellung aus glykosaminoglykanen
KR930005625A (ko) 생체의 에너지 보급용 당(糖) 및 그 용도
Uda et al. Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: injectable material for bone augmentation
CA2070803A1 (fr) Materiau implantable biodegradable et procede de fabrication

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee